...
首页> 外文期刊>Journal of Medicinal Chemistry >Development of a Highly Potent Analogue and a Long-Acting Analogue of Oxytocin for the Treatment of Social Impairment-Like Behaviors
【24h】

Development of a Highly Potent Analogue and a Long-Acting Analogue of Oxytocin for the Treatment of Social Impairment-Like Behaviors

机译:开发高强度模拟和催产素的长效类似物,用于治疗社会障碍的行为

获取原文
获取原文并翻译 | 示例

摘要

The nonapeptide hormone oxytocin (OT) has pivotal brain roles in social recognition and interaction and is thus a promising therapeutic drug for social deficits. Because of its peptide structure, however, OT is rapidly eliminated from the bloodstream, which decreases its potential therapeutic effects in the brain. We found that newly synthesized OT analogues in which the Pro(7) of OT was replaced with N-(p-fluorobenzyl)glycine (2) or N-(3-hydroxypropyl)glycine (5) exhibited highly potent binding affinities for OT receptors and Ca2+ mobilization effects by selectively activating OT receptors over vasopressin receptors in HEK cells, where 2 was identified as a superagonist (E-Max = 131%) for OT receptors. Furthermore, the two OT analogues had a remarkably long-acting effect, up to 16-24 h, on recovery from impaired social behaviors in two strains of CD38 knockout mice that exhibit autism spectrum disorder-like social behavioral deficits, whereas the effect of OT itself rapidly diminished.
机译:非肽激素催产素(OT)在社会识别和相互作用中具有枢转脑作用,因此是一个有助于社会赤字的治疗药。然而,由于其肽结构,从血液中迅速消除OT,这降低了其在大脑中的潜在治疗效果。我们发现,用N-(P-氟苄基)甘氨酸(2)或N-(3-羟丙基)甘氨酸(5)代替OT的新合成的OT类似物,其中OT受体表现出高效的结合亲和力通过在HEK细胞中选择性地激活血管加压素受体上的OT受体来选择性地激活CA2 +动员效果,其中2被鉴定为OT受体的超方(E-MAX = 131%)。此外,两个OT类似物具有显着的长效效果,高达16-24小时,从两种CD38敲除小鼠中的社会行为受损的恢复,表现出自闭症谱系障碍的社会行为赤字,而OT的效果本身迅速减少。

著录项

  • 来源
    《Journal of Medicinal Chemistry 》 |2019年第7期| 共14页
  • 作者单位

    Hokkaido Univ Fac Pharmaceut Sci Sapporo Hokkaido 0600812 Japan;

    Kanazawa Univ Grad Sch Med Sci Res Ctr Child Mental Dev Dept Basic Res Social Recognit Kanazawa Ishikawa 9208640 Japan;

    Kanazawa Univ Grad Sch Med Sci Res Ctr Child Mental Dev Dept Basic Res Social Recognit Kanazawa Ishikawa 9208640 Japan;

    Kanazawa Univ Grad Sch Med Sci Res Ctr Child Mental Dev Dept Basic Res Social Recognit Kanazawa Ishikawa 9208640 Japan;

    Kanazawa Univ Grad Sch Med Sci Res Ctr Child Mental Dev Dept Basic Res Social Recognit Kanazawa Ishikawa 9208640 Japan;

    Tohoku Univ Fac Pharmaceut Sci Sendai Miyagi 9808574 Japan;

    Tohoku Univ Fac Pharmaceut Sci Sendai Miyagi 9808574 Japan;

    Kanazawa Univ Grad Sch Med Sci Dept Biochem &

    Mol Vasc Biol Kanazawa Ishikawa 9208640 Japan;

    Kanazawa Univ Grad Sch Med Sci Dept Biochem &

    Mol Vasc Biol Kanazawa Ishikawa 9208640 Japan;

    Kanazawa Univ Adv Sci Res Ctr Kanazawa Ishikawa 9208640 Japan;

    Kanazawa Univ Adv Sci Res Ctr Kanazawa Ishikawa 9208640 Japan;

    Kanazawa Univ Adv Sci Res Ctr Kanazawa Ishikawa 9208640 Japan;

    Hokkaido Univ Fac Pharmaceut Sci Sapporo Hokkaido 0600812 Japan;

    Tohoku Univ Fac Pharmaceut Sci Sendai Miyagi 9808574 Japan;

    Kanazawa Univ Grad Sch Med Sci Res Ctr Child Mental Dev Dept Basic Res Social Recognit Kanazawa Ishikawa 9208640 Japan;

    Hokkaido Univ Fac Pharmaceut Sci Sapporo Hokkaido 0600812 Japan;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学 ;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号